Assisted Reproductive Technologies: Quality and Safety

Worldwide, approximately 500,000 in vitro fertilization cycles are performed every year. Although the best possible result is a healthy child, the technology carries a number of varying risks and complications leading to a trade-off between the efficacy of these treatments and their quality and safety. Drawing on contributions from international experts with academic and clinical backgrounds, Assisted Reproductive Technologies: Quality and Safety presents an analysis of the medical risks and complications involved in reproductive medicine. Putting the intricacies of reproductive health in the spotlight, the book describes side-effects, risks, and complications related to ART treatments. It discusses ovarian hyperstimulation syndrome, demonstrates the impact of judicious elective single embryo transfer, and focuses heavily on multiple pregnancy as the major risk factor of ART. The editors highlight the relatively less likely, but important risks of oncogenic complications, bleeding at the time of ovum retrieval, and the even smaller but still existing risk for maternal mortality. They include discussions of non-medical factors that can have a major impact on people's lives such as psychological, sexual, financial, moral, ethical, and philosophical dilemmas. In today's litigious climate, modern management of any clinic is all about minimizing risks and complications. Thoroughly addressing quality and safety issues in ART, this book provides succinct, up-to-date information on quality care in reproductive medicine.

Jan Gerris MD PhD is Professor of Obstetrics, Gynecology & Fertility, Middelheim Hospital, Antwerp, BelgiumFrançois Olivennes MD PhD is Professor of Reproductive Medicine, Hôpital Cochin, Paris, FrancePetra De Sutter MD PhD is Professor at the Centre for Reproductive Medicine, Ghent University Hospital, Ghent, Belgium